ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Marijuana Inc (PK)

Marijuana Inc (PK) (MAJI)

0.05105
0.00
( 0.00% )
Updated: 07:44:53

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Rendering Error

MAJI Financials

Financials
Rendering Error

MAJI Discussion

View Posts
i_like_bb_stock i_like_bb_stock 23 hours ago
news https://www.otcmarkets.com/stock/MAJI/news/Exousia-Pro-Officially-Announces-the-Production-of-Plant-Based-Exosomes-Has-Begun?id=471458
👍️0
samson8 samson8 2 days ago
Man you are the top signal on everything you promote.
👍️0
bjl bjl 1 week ago
$MAJI News - #ExousiaPro was able to renegotiate a 20% reduction in the Japanese licensing deal that was acquired by Exousia AI. Worldwide rights now secure the #exosome DNA loading patent. Best in Breed #distruptive #exosomal loading technology. Committed to minimizing dilution and maximizing long term shareholder value.
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/exousia-has-successfully-renegotiated-its-license-agreement-1001807
$MAJI News - #ExousiaPro was able to renegotiate a 20% reduction in the Japanese licensing deal that was acquired by Exousia AI. Worldwide rights now secure the #exosome DNA loading patent. Best in Breed #distruptive #exosomal loading technology. Committed to minimizing dilution… pic.twitter.com/FtMYc2zbDd— Exousia Pro (@Exousia_Pro) March 18, 2025
🔥 1
i_like_bb_stock i_like_bb_stock 1 week ago
news https://www.otcmarkets.com/stock/MAJI/news/story?e&id=3178752
👍️0
Mpphotopro Mpphotopro 1 week ago
Maji news out
👍️0
i_like_bb_stock i_like_bb_stock 1 week ago
bout to break .10, float is locked up, same ceo as $BIXT and only 6M dtc float shares, news flow coming, think more will come down to the otc with small caps waining
👍️ 2
i_like_bb_stock i_like_bb_stock 1 week ago
thx
👍️ 1
bjl bjl 1 week ago
To better align its reporting with standard calendar cycles, Exousia Pro ( $MAJI ) filed an extension yesterday to extend the deadline for its next report. This extension allows the Company to finalize its fiscal year-end change to December 31st, in cooperation with OTC Markets. The annual report is complete and ready for submission upon the successful conclusion of this fiscal adjustment, at which point $MAJI will also transition to calendar-based quarterly reporting. We are committed to transparency and will provide further updates as they become available later this week.
To better align its reporting with standard calendar cycles, Exousia Pro ( $MAJI ) filed an extension yesterday to extend the deadline for its next report. This extension allows the Company to finalize its fiscal year-end change to December 31st, in cooperation with OTC Markets.… pic.twitter.com/4zK9Pc1NrH— Exousia Pro (@Exousia_Pro) March 18, 2025
👍️0
i_like_bb_stock i_like_bb_stock 1 week ago
think so too
👍️ 1
i_like_bb_stock i_like_bb_stock 1 week ago
its an entirely diff stock now
👍️0
$theDDmessiah $theDDmessiah 1 week ago
Gonna blow up next week! 
👍️0
trader59 trader59 2 weeks ago
Seriously?
No legitimate company would attach themselves to the carcass of the Justin Costello scam that was run here. Another bottom feeder pump and dump.
👍️0
$theDDmessiah $theDDmessiah 2 weeks ago
Nice getting found! Should see .23 soon super thin with alot of catalysts Biotechs are great and fly like bat on covid outta hell lol
👍️0
i_like_bb_stock i_like_bb_stock 2 weeks ago
yes
👍️0
i_like_bb_stock i_like_bb_stock 2 weeks ago
$MAJI—DBA Exousai Pro is pleased to announce that the name change and symbol change were filed last week with FINRA. We expect some minor comments, but not the lengthy review process, as the Company completed a name change in October 2024 that took 18 months. The Company will…— Exousia Pro (@Exousia_Pro) March 14, 2025
👍️0
bjl bjl 2 weeks ago
$MAJI—DBA Exousai Pro is pleased to announce that the name change and symbol change were filed last week with FINRA. We expect some minor comments, but not the lengthy review process, as the Company completed a name change in October 2024 that took 18 months. The Company will begin issuing news more regularly now that this has been completed.
$MAJI—DBA Exousai Pro is pleased to announce that the name change and symbol change were filed last week with FINRA. We expect some minor comments, but not the lengthy review process, as the Company completed a name change in October 2024 that took 18 months. The Company will…— Exousia Pro (@Exousia_Pro) March 14, 2025
👍️0
i_like_bb_stock i_like_bb_stock 2 weeks ago
took some 6M float, no news since Jan. would think we'd see something soon, Michael Sheikh is a great CEO, doesn't dump on you. This has so much potential 🚨 $MAJI 🚨
CCO OF BIXT is the CEO of $MAJI
if you like $BIXT you will love MAJI
Huge upside low float moves on air it seems! On high alert .14 test level stop. Getting found! THE next 10x biotech play. Should do well imo! On high alert! Cheap .10 and under great entry!… pic.twitter.com/SWe5ZHpS27— $DDKING (@JusticeleagueDD) March 14, 2025
👍️0
meitze meitze 4 weeks ago
Where is marijuana inc? What the F is going on?. Left high and dry with only a shitty video presentation to go on. All talk in November and BS ever since.
👍️0
meitze meitze 4 weeks ago
These guys didn't waste any time lying to shareholders. Lol.
👍️0
meitze meitze 1 month ago
You can't even sell this turd. Where is the MJ company? Where is the news? Where r the filings and PRs that were promised in October? All BS as usual.
👍️0
JStewin JStewin 1 month ago
What material changes can we expect to support this position? There seems to be very little interest.
👍️0
meitze meitze 1 month ago
The last M is magic? JC, run!
👍️0
bjl bjl 1 month ago
$MAJI Shareholders | We’re thrilled to share the launch of our new Youtube channel for our company that’s determined to make a difference in the fight against cancer. In our latest video, our CEO Mike Sheikh outlines some of the exciting work we’ve begun - Stay Tuned!

$MAJI Shareholders | We’re thrilled to share the launch of our new Youtube channel for our company that’s determined to make a difference in the fight against cancer. In our latest video, our CEO Mike Sheikh outlines some of the exciting work we’ve begun - Stay Tuned! #OTC…— Exousia Pro (@Exousia_Pro) February 10, 2025

👍️0
JStewin JStewin 2 months ago
dead?
👍️ 1
meitze meitze 2 months ago
GRNF all over again.
👍️0
bjl bjl 2 months ago
ExousiaPro-Investor-Presentation-Deck

https://exousiapro.com/wp-content/uploads/2025/02/ExousiaPro-Investor-Presntation-Deck-1-31-25.pdf

MAJI
👍️0
alstocks alstocks 2 months ago
a 3 to 5 million float eom
👍️0
JStewin JStewin 2 months ago
Is there any reason to see upside here anymore? waiting for signatures and approvals in OTC is usually more exciting than when it happens.... bc it never does.
👍️ 1
meitze meitze 2 months ago
LOL, another JC i guess. Ghost town again.
👍️0
bjl bjl 2 months ago
$MAJI - The transfer agent has made the reduction and reduced the A/S to 250,000,000! OTC should reflect this during its next update

$MAJI - The transfer agent has made the reduction and reduced the A/S to 250,000,000! OTC should reflect this during its next update... pic.twitter.com/8gP07i5woy— Exousia Pro (@Exousia_Pro) January 24, 2025
👍️0
meitze meitze 2 months ago
As the pps erodes with no updates. Back to .01
👍️0
Stujam Stujam 2 months ago
More sells than buys
👍️0
bjl bjl 2 months ago
Wow, just got back home, what happened to the sp?

$MAJI Lots of follow up ongoing from the #JPM25 conference in terms of licensing partners. Key connections made with a number of big pharma’s. Accomplished 2 presentations to Healthcare investment bankers at the conference. The feedback was positive. Expect to release slide deck before
@golly Feb 25

$MAJI Lots of follow up ongoing from the #JPM25 conference in terms of licensing partners.  Key connections made with a number of big pharma’s. Accomplished 2 presentations to Healthcare investment bankers at the conference. The feedback was positive. Expect to release slide deck… pic.twitter.com/wBSM5U0P0V— Exousia Pro (@Exousia_Pro) January 23, 2025
👍️0
136 136 2 months ago
Volume is very light right now across almost all of the small/micro cap OTCs. .... and MAJI is still super undiscovered.

I believe we will see our .10-.25 breakout with 1-2 weeks

The CEO has been great to chat with -- there's a lot to be excited about in the very near term.

You can contact him if you need any reassurances on where the company is going

$MAJI

MAJI
👍️0
meitze meitze 2 months ago
Somebody needs to tell MAJI the market is open. Holidays are over, let's go. Volume needed.
👍️0
bjl bjl 2 months ago
Good morning $MAJI Shareholders || Our CEO, Mike Sheikh, is in San Francisco at the J.P. Morgan 43rd Annual Healthcare Conference 2025 representing ExousioPRO! Very exciting time as he will be networking & conducting presentations about our #exosome #oncology treatment. More to come after Mike gets back.

Good morning $MAJI Shareholders || Our CEO, Mike Sheikh, is in San Francisco at the J.P. Morgan 43rd Annual Healthcare Conference 2025 representing ExousioPRO!  Very exciting time as he will be networking & conducting presentations about our #exosome #oncology treatment. More to… pic.twitter.com/083JCJn1EY— Exousia Pro (@Exousia_Pro) January 13, 2025

MAJI
👍️ 1
136 136 2 months ago
Actually a really nice development. Management showing they mean business and care about not diluting.

So many dilution machine pieces of shit on the OTC, refreshing to see that’s not the case here.

Wont be long til we are .10 - .20 range IMO

$MAJI

MAJI
👍️0
bjl bjl 2 months ago
47 mil common shares now cancelled, being replaced by preferred shares

Good Morning $MAJI Shareholders | Excited to announce this corporate update, to further highlight management's commitment to shareholder value as we enter the company's growth phase. More to come shortly, stay tuned!

Good Morning $MAJI Shareholders | Excited to announce this corporate update, to further highlight management's commitment to shareholder value as we enter the company's growth phase. More to come shortly, stay tuned! #OTC #NASDAQ #Pennystocks #Exosomes #Stocks pic.twitter.com/xLG2AxfVTg— Exousia Pro (@Exousia_Pro) January 10, 2025

MAJI
👍️ 1
meitze meitze 3 months ago
I didn't need to do homework to know what was coming. A big fat joke as usual in the otc. Fake advisors, fake profiles, all scams nearly.
👍️0
eqinvestor eqinvestor 3 months ago
Do some homework. New CEO was with BIXT. BIXT is a joke run by David Platt who ran one healthcare company into the ground and who has been telling the same BS science story for well over 10 years New CEO claims to have worked for Dean Witter and National. There is no such person I can find on the FINRA site who was registered under that name. 
👍️0
meitze meitze 3 months ago
Less interest in the stock now than before the news came out yesterday. Lol. 0 volume so far.
👍️0
bjl bjl 3 months ago
$MAJI Shareholders | Exousia is in talks to license several other patents using Exosomes, which, once secured, will allow the company to expand its oncology studies beyond GBM. More to come on this later. #Glioblastoma #Cancer

$MAJI Shareholders | Exousia is in talks to license several other patents using Exosomes, which, once secured, will allow the company to expand its oncology studies beyond GBM. More to come on this later. #Glioblastoma #Cancer pic.twitter.com/F2Q81t3dcp— Exousia Pro (@Exousia_Pro) January 7, 2025

MAJI
👍️0
bjl bjl 3 months ago
$MAJI Shareholders | To show that shareholder value is priority #1 for us, the issued shares will be restricted for 21 months. Assuming 15 months for an uplist followed by a lockup agreement for another 6 months.

$MAJI Shareholders | To show that shareholder value is priority #1 for us, the issued shares will be restricted for 21 months. Assuming 15 months for an uplist followed by a lockup agreement for another 6 months. #ShareholderValue #Growth pic.twitter.com/wCSuFUNEF2— Exousia Pro (@Exousia_Pro) January 6, 2025

MAJI
👍️0
bjl bjl 3 months ago
Marijuana, Inc., Completes Acquisition of Exousia AI and Enters Expanding Exosome Market

ST. PETERSBURG, Fla., Jan. 6, 2025 /PRNewswire/ -- Marijuana, Inc. (OTCPINK: MAJI), dba Exousia Pro, Inc., has acquired 100% of Exousia AI in a cash and stock transaction from Ludwig Enterprises, Inc. Exousia Pro will issue 47,000,000 million restricted shares of its Common stock to Ludwig Enterprises.
The 47,000,000 shares being issued are restricted shares with certain lock-up features. The legend cannot be removed until six months AFTER Exousia Pro has completed its up-listing with NASDAQ or an equivalent exchange. The Company further agreed to assume liabilities under $75,000 and issued Ludwig a Note for $100,000.
Exousia AI is a leading USA-based biotechnology company in the field of Exosomes. The Company secured a worldwide license for its Exosome technology. The technology covers growing and extracting plant-based exosomes and loading them for use as a drug delivery system. The loading process can also be applied to human-derived exosomes. The acquisition includes an ongoing study on using Exosomes to treat Glioblastoma ("GBM"). The study is well underway, with very promising initial findings. Exousia AI is involved in other studies, including one study concluding in Italy. Exousia Pro will enter two additional studies covering dermatology and the dental market that are part of the acquisition.
Exousia Pro will manufacture and sell vials of wet exosomes or jars of dried exosomes to the nutraceutical and dermatology markets. The OTC exosome market, known as cosmeceuticals, is rapidly expanding due to consumer demand for antiaging and regenerative skincare solutions. A 30-day treatment for skin and hair sells for $400 a vial. Reports suggest a compound annual growth rate of 10%, growing from $310 million in 2025 to $633 million in 2033, for the exosomes skincare market; this is a global trend, with markets in North America, Europe, and Asia Pacific showing strong growth.
Exousia is in talks to license several other patents using Exosomes, which, once secured, will allow the Company to expand its oncology studies beyond GBM.
When Exousia Pro proves its technology enhances current chemotherapy drugs on the market, it can contact the drug manufacturers and license the tech for use in their drug therapy.
"The exosome market is in its infancy, but poised for explosive growth, as evidence by a surge of promising studies," said CEO of Marijuana Inc., Michael Sheikh. "Mounting research points to the vast therapeutic potential of exosomes, highlighting their capacity to precisely target diseases while minimizing side effects. Investors may not fully appreciate the dominance of monoclonal antibodies, which now lead the pharmaceutical market in revenue. This success stems from their ability to target diseased cells, often delivering therapeutic payloads directly where needed. Every major pharmaceutical company is actively developing monoclonal antibody drugs, driven by the universal desire for treatments that alleviate symptoms without causing new ones."
"Exosomes represent the next generation of targeted therapies, surpassing monoclonal antibodies in several key aspects. They offer significant cost advantages in production, the capacity to deliver larger and more complex payloads, including sensitive molecules like DNA, and a broader range of applications. Importantly, exosomes also mitigate the risk of off-target effects and immune reactions often associated with current monoclonal antibody treatments. This would be a key selling point in the event of licensing discussions. Exosomes embody an elegant evolution in biotechnology, and Exousia Pro is committed to spearheading their commercialization and therapeutic development."


https://finance.yahoo.com/news/marijuana-inc-completes-acquisition-exousia-140000497.html
👍️0
bjl bjl 3 months ago
Stay tuned

pic.twitter.com/wXJZNPzY3K— Exousia Pro (@Exousia_Pro) January 1, 2025
👍️0
bjl bjl 3 months ago
Yes, would like to see some insider buys to start the new year.

MAJI
👍️0
136 136 3 months ago
Start of January 2025 is planned news for $MAJI . Expecting we start to breakout here

.07+ coming quick imo

MAJI
👍️0
bjl bjl 3 months ago
We plan to start 2025 with a bang, so please keep checking back and stay tuned!

Good Morning $MAJI Shareholders: We would like to take a moment and wish everyone a very safe and wonderful holiday! We plan to start 2025 with a bang, so please keep checking back and stay tuned! pic.twitter.com/10PtNRIzkF— Exousia Pro (@Exousia_Pro) December 24, 2024

MAJI
👍️0
bjl bjl 3 months ago
Exousia Pro filed the Amendment for our Articles to reduce the Authorized shares from 750 million to 250 million today. The filing should be visible on http://sunbiz.org by January 2, 2025.

#Exousia Pro filed the Amendment for our Articles to reduce the Authorized shares from 750 million to 250 million today. The filing should be visible on https://t.co/Jp3Z2Km5zR by January 2, 2025.$MAJI pic.twitter.com/8Eqdxru1RC— Exousia Pro (@Exousia_Pro) December 20, 2024

$MAJI
👍️ 2
136 136 3 months ago
Just a pathetic bash attempt. It’s a good sign he showed up though, thats how you know this is about to take off.

Classic

$MAJI

MAJI
👍️0

Your Recent History

Delayed Upgrade Clock